Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Antibacterial bioactive glass for European markets

26.10.2004


Two new products have been approved to European medical markets: antibacterial bioactive glass granules for remedying frontal sinus and bone defects and a bioactive glass plate for the repair of the orbital floor.



The products, registered by a Finnish biomaterials company Vivoxid Ltd are aimed at solving medical problems in the head and neck area.

Bioactive glass products hold substantial commercial potential. Bioactive glass offers a number of new application areas in the future in medicine and dentistry. Vivoxid has a wide development programme of new bioactive glass products. Tekes, the National Technology Agency of Finland, has funded Vivoxid’s R&D work.


Long-term achievement

“The first scientific studies with bioactive glass were conducted, as early as the middle of the 80’s at Åbo Akademi University (Turku, Finland) and at the University of Turku. The present achievement has been preceded by thorough clinical research at the University Hospital of Turku for over ten years”, says Vivoxid’s CEO Kauko Kurkela.

Vivoxid’s products can be used for curing frontal sinus and bone defects in the treatment of chronic infections of the frontal sinus. The material enhances the growth of new bone, sustains the formed bone and has antibacterial effects. Clinical experience from the past ten years has been very positive.

One of Vivoxid’s CE approved bioactive glass products is a solid plate for the reconstruction of a bro-ken orbital floor, often caused by sporting injuries, accidents or violence, for example.

Substantial commercial potential

Around 20 000 operations are performed worldwide in both the aforementioned indications. Although the products are currently for a niche market as registered for cranial indications, they hold substantial commercial potential after being further developed for much wider indication areas such as the ortho-paedic area.

After entering the European markets, the company intends to focus on the markets in North America, Japan and other countries.

Mira Banerjee | alfa
Further information:
http://www.tekes.fi
http://www.vivoxid.com

More articles from Health and Medicine:

nachricht FAU researchers demonstrate that an oxygen sensor in the body reduces inflammation
22.02.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

nachricht 'Icebreaker' protein opens genome for t cell development, Penn researchers find
21.02.2018 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Developing reliable quantum computers

International research team makes important step on the path to solving certification problems

Quantum computers may one day solve algorithmic problems which even the biggest supercomputers today can’t manage. But how do you test a quantum computer to...

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Hybrid optics bring color imaging using ultrathin metalenses into focus

For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.

But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...

Im Focus: Stem cell divisions in the adult brain seen for the first time

Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.

The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

The RWI/ISL-Container Throughput Index started off well in 2018

22.02.2018 | Business and Finance

FAU researchers demonstrate that an oxygen sensor in the body reduces inflammation

22.02.2018 | Health and Medicine

Histology in 3D: new staining method enables Nano-CT imaging of tissue samples

22.02.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>